J&J Called a ‘Kingpin’ in Opioid Case That Could Be a Test for 1,600 More Lawsuits

On Day 6 of the opioid trial against pharmaceutical giant Johnson & Johnson–a trial that is expected to last two months–Oklahoma’s Attorney General Mike Hunter decided to give a press conference to recap some of the takeaways from the proceedings so far. Among his points: At the height of the opioid epidemic, J&J’s sales representatives […]

Will Functional Genomics Cure Big Pharma’s Failure Rate?

Drug discovery is a notoriously expensive and inefficient endeavor. Nine of 10 drug candidates that go through the cost-intensive, years-long clinical trial process never make it to market. That 90% failure rate–a drag on medical progress and a factor often cited by pharmaceutical companies to justify sky-high drug prices–has proven frustratingly sticky even in an […]